AFP and hepatocellular carcinoma: Similar performance was seen with the differentiation of all-stage HCC from benign CLD, again with GAAD showing the highest AUC versus AFP or PIVKA-II (94.9% vs. 89% vs. 87.3%, respectively, Figure 3B).